410 related articles for article (PubMed ID: 22614004)
21. BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha.
Pi X; Garin G; Xie L; Zheng Q; Wei H; Abe J; Yan C; Berk BC
Circ Res; 2005 Jun; 96(11):1145-51. PubMed ID: 15879308
[TBL] [Abstract][Full Text] [Related]
22. Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch.
Magnon C; Opolon P; Ricard M; Connault E; Ardouin P; Galaup A; Métivier D; Bidart JM; Germain S; Perricaudet M; Schlumberger M
J Clin Invest; 2007 Jul; 117(7):1844-55. PubMed ID: 17557121
[TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
24. SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo.
Chao WR; Amin K; Shi Y; Hobbs P; Tanabe M; Tanga M; Jong L; Collins N; Peters R; Laderoute K; Dinh D; Yean D; Hou C; Sato B; Alt C; Sambucetti L
Angiogenesis; 2011 Mar; 14(1):1-16. PubMed ID: 21104121
[TBL] [Abstract][Full Text] [Related]
25. High glucose concentrations attenuate hypoxia-inducible factor-1alpha expression and signaling in non-tumor cells.
Dehne N; Hintereder G; Brüne B
Exp Cell Res; 2010 Apr; 316(7):1179-89. PubMed ID: 20184881
[TBL] [Abstract][Full Text] [Related]
26. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
27. SOHLH2 Suppresses Angiogenesis by Downregulating HIF1α Expression in Breast Cancer.
Cui W; Xiao Y; Zhang R; Zhao N; Zhang X; Wang F; Liu Y; Zhang X; Hao J
Mol Cancer Res; 2021 Sep; 19(9):1498-1509. PubMed ID: 34158392
[TBL] [Abstract][Full Text] [Related]
28. Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signalling.
Park SY; Nho CW; Kwon DY; Kang YH; Lee KW; Park JH
Br J Nutr; 2013 Jan; 109(2):210-22. PubMed ID: 22716951
[TBL] [Abstract][Full Text] [Related]
29. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
[TBL] [Abstract][Full Text] [Related]
30. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation.
Kumar A; Kant S; Singh SM
Chem Biol Interact; 2012 Jul; 199(1):29-37. PubMed ID: 22705712
[TBL] [Abstract][Full Text] [Related]
31. Matairesinol inhibits angiogenesis via suppression of mitochondrial reactive oxygen species.
Lee B; Kim KH; Jung HJ; Kwon HJ
Biochem Biophys Res Commun; 2012 Apr; 421(1):76-80. PubMed ID: 22483751
[TBL] [Abstract][Full Text] [Related]
32. The mineral dust-induced gene,
Zhou H; Geng F; Chen Y; Du J; Zhang X; Liu B; Song D; Hou H; Zhao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760153
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.
Del Bufalo D; Ciuffreda L; Trisciuoglio D; Desideri M; Cognetti F; Zupi G; Milella M
Cancer Res; 2006 Jun; 66(11):5549-54. PubMed ID: 16740688
[TBL] [Abstract][Full Text] [Related]
34. In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.
Anderson KM; Jajeh J; Guinan P; Rubenstein M
Anticancer Res; 2009 Nov; 29(11):4579-88. PubMed ID: 20032407
[TBL] [Abstract][Full Text] [Related]
35. Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-inducible transcription factor complex.
Dubey R; Levin MD; Szabo LZ; Laszlo CF; Kushal S; Singh JB; Oh P; Schnitzer JE; Olenyuk BZ
J Am Chem Soc; 2013 Mar; 135(11):4537-49. PubMed ID: 23448368
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
Li Y; Zhang D; Wang X; Yao X; Ye C; Zhang S; Wang H; Chang C; Xia H; Wang YC; Fang J; Yan J; Ying H
Sci Rep; 2015 Jul; 5():12495. PubMed ID: 26205124
[TBL] [Abstract][Full Text] [Related]
37. Unraveling galectin-1 as a novel therapeutic target for cancer.
Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.
Liang H; Xiao J; Zhou Z; Wu J; Ge F; Li Z; Zhang H; Sun J; Li F; Liu R; Chen C
Oncogene; 2018 Apr; 37(15):1961-1975. PubMed ID: 29367761
[TBL] [Abstract][Full Text] [Related]
39. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.
Marín-Hernández A; Gallardo-Pérez JC; Ralph SJ; Rodríguez-Enríquez S; Moreno-Sánchez R
Mini Rev Med Chem; 2009 Aug; 9(9):1084-101. PubMed ID: 19689405
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial mutations contribute to HIF1alpha accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenease kinase 2 in head and neck squamous cell carcinoma.
Sun W; Zhou S; Chang SS; McFate T; Verma A; Califano JA
Clin Cancer Res; 2009 Jan; 15(2):476-84. PubMed ID: 19147752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
